Viewing Study NCT01970904

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:54 PM
Ignite Modification Date: 2026-02-03 @ 11:40 PM
Study NCT ID: NCT01970904
Status: COMPLETED
Last Update Posted: 2016-04-20
First Post: 2013-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients
Sponsor: Debiopharm International SA
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C View
None Liver Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic hepatitis C View
None DEB025 View
None Alisporivir View
None ribavirin therapy View
None genotype 2/3 treatment naive patients View